Works matching IS 00207136 AND DT 2021 AND VI 149 AND IP 2

Results: 27
    1
    2
    3
    4

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    5
    6

    Erratum.

    Published in:
    2021
    Publication type:
    Correction Notice
    7
    8
    9
    10

    Outcomes on anti‐VEGFR‐2/paclitaxel treatment after progression on immune checkpoint inhibition in patients with metastatic gastroesophageal adenocarcinoma.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 378, doi. 10.1002/ijc.33559
    By:
    • Kankeu Fonkoua, Lionel A.;
    • Chakrabarti, Sakti;
    • Sonbol, Mohamad B.;
    • Kasi, Pashtoon M.;
    • Starr, Jason S.;
    • Liu, Alex J.;
    • Nevala, Wendy K.;
    • Maus, Rachel L.;
    • Bois, Melanie C.;
    • Pitot, Henry C.;
    • Chandrasekharan, Chandrikha;
    • Ross, Helen J.;
    • Wu, Tsung‐Teh;
    • Graham, Rondell P.;
    • Villasboas, Jose C.;
    • Weiss, Matthias;
    • Foster, Nathan R.;
    • Markovic, Svetomir N.;
    • Dong, Haidong;
    • Yoon, Harry H.
    Publication type:
    Article
    11

    Clinical impact of probiotics on the efficacy of anti‐PD‐1 monotherapy in patients with nonsmall cell lung cancer: A multicenter retrospective survival analysis study with inverse probability of treatment weighting.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 473, doi. 10.1002/ijc.33557
    By:
    • Takada, Kazuki;
    • Shimokawa, Mototsugu;
    • Takamori, Shinkichi;
    • Shimamatsu, Shinichiro;
    • Hirai, Fumihiko;
    • Tagawa, Tetsuzo;
    • Okamoto, Tatsuro;
    • Hamatake, Motoharu;
    • Tsuchiya‐Kawano, Yuko;
    • Otsubo, Kohei;
    • Inoue, Koji;
    • Yoneshima, Yasuto;
    • Tanaka, Kentaro;
    • Okamoto, Isamu;
    • Nakanishi, Yoichi;
    • Mori, Masaki
    Publication type:
    Article
    12

    Pegilodecakin as monotherapy or in combination with anti‐PD‐1 or tyrosine kinase inhibitor in heavily pretreated patients with advanced renal cell carcinoma: Final results of cohorts A, G, H and I of IVY Phase I study.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 403, doi. 10.1002/ijc.33556
    By:
    • Tannir, Nizar M.;
    • Papadopoulos, Kyriakos P.;
    • Wong, Deborah J.;
    • Aljumaily, Raid;
    • Hung, Annie;
    • Afable, Manuel;
    • Kim, Jong Seok;
    • Ferry, David;
    • Drakaki, Alexandra;
    • Bendell, Johanna;
    • Naing, Aung
    Publication type:
    Article
    13

    Cervical lesion assessment using real‐time microendoscopy image analysis in Brazil: The CLARA study.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 431, doi. 10.1002/ijc.33543
    By:
    • Hunt, Brady;
    • Fregnani, José Humberto Tavares Guerreiro;
    • Brenes, David;
    • Schwarz, Richard A.;
    • Salcedo, Mila P.;
    • Possati‐Resende, Júlio César;
    • Antoniazzi, Márcio;
    • Oliveira Fonseca, Bruno;
    • Santana, Iara Viana Vidigal;
    • Macêdo Matsushita, Graziela;
    • Castle, Philip E.;
    • Schmeler, Kathleen M.;
    • Richards‐Kortum, Rebecca
    Publication type:
    Article
    14

    Outcomes of patients with intermediate‐risk or poor‐risk metastatic renal cell carcinoma who received their first cycle of nivolumab and ipilimumab in the hospital because of symptomatic disease: The MD Anderson Cancer Center experience.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 387, doi. 10.1002/ijc.33560
    By:
    • Alhalabi, Omar;
    • Hasanov, Elshad;
    • Wilson, Nathaniel R.;
    • Araujo, John;
    • Wang, Jianbo;
    • Campbell, Matthew T.;
    • Goswami, Sangeeta;
    • Shah, Amishi Y.;
    • Gao, Jianjun;
    • Msaouel, Pavlos;
    • Tannir, Nizar M.
    Publication type:
    Article
    15
    16

    Stereotactic or conformal radiotherapy for adrenal metastases: Patient characteristics and outcomes in a multicenter analysis.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 358, doi. 10.1002/ijc.33546
    By:
    • Buergy, Daniel;
    • Würschmidt, Florian;
    • Gkika, Eleni;
    • Hörner‐Rieber, Juliane;
    • Knippen, Stefan;
    • Gerum, Sabine;
    • Balermpas, Panagiotis;
    • Henkenberens, Christoph;
    • Voglhuber, Theresa;
    • Kornhuber, Christine;
    • Barczyk, Steffen;
    • Röper, Barbara;
    • Rashid, Ali;
    • Blanck, Oliver;
    • Wittig, Andrea;
    • Herold, Hans‐Ulrich;
    • Brunner, Thomas B.;
    • Klement, Rainer J.;
    • Kahl, Klaus Henning;
    • Ciernik, Ilja F.
    Publication type:
    Article
    17
    18

    Expression quantitative trait loci of genes predicting outcome are associated with survival of multiple myeloma patients.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 327, doi. 10.1002/ijc.33547
    By:
    • Macauda, Angelica;
    • Piredda, Chiara;
    • Clay‐Gilmour, Alyssa I.;
    • Sainz, Juan;
    • Buda, Gabriele;
    • Markiewicz, Miroslaw;
    • Barington, Torben;
    • Ziv, Elad;
    • Hildebrandt, Michelle A. T.;
    • Belachew, Alem A.;
    • Varkonyi, Judit;
    • Prejzner, Witold;
    • Druzd‐Sitek, Agnieszka;
    • Spinelli, John;
    • Andersen, Niels Frost;
    • Hofmann, Jonathan N.;
    • Dudziński, Marek;
    • Martinez‐Lopez, Joaquin;
    • Iskierka‐Jazdzewska, Elzbieta;
    • Milne, Roger L.
    Publication type:
    Article
    19
    20
    21
    22
    23
    24
    25
    26

    Issue Information.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 241, doi. 10.1002/ijc.33084
    Publication type:
    Article
    27

    Issue Information.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 2, p. 483, doi. 10.1002/ijc.33083
    Publication type:
    Article